Yael Dishon Benattar
Overview
Explore the profile of Yael Dishon Benattar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
441
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Legg A, Roberts M, Davies J, Cass A, Meagher N, Sud A, et al.
Open Forum Infect Dis
. 2023 Jul;
10(7):ofad337.
PMID: 37496601
Background: The Combination Antibiotic Therapy for Methicillin-Resistant (CAMERA2) trial ceased recruitment in July 2018, noting that a higher proportion of patients in the intervention arm (combination therapy) developed acute kidney...
2.
Kon H, Hameir A, Nutman A, Temkin E, Keren Paz A, Lellouche J, et al.
Microbiol Spectr
. 2023 May;
11(3):e0509322.
PMID: 37219426
Colistin heteroresistance (HR) refers to a bacterial population comprised of several subpopulations with different levels of resistance to colistin. In this study, we discuss the classic form of HR, in...
3.
Frenk S, Temkin E, Lurie-Weinberger M, Keren-Paz A, Rov R, Rakovitsky N, et al.
J Antimicrob Chemother
. 2022 Jan;
77(4):934-943.
PMID: 35084023
Objectives: To describe the population genetics and antibiotic resistance gene distribution of carbapenem-resistant Acinetobacter baumannii (CRAB) isolates causing infections in three Mediterranean countries. Methods: Isolates were collected during the 2013-17...
4.
Daitch V, Paul M, Daikos G, Durante-Mangoni E, Yahav D, Carmeli Y, et al.
BMC Infect Dis
. 2021 Apr;
21(1):309.
PMID: 33789574
Background: Population external validity is the extent to which an experimental study results can be generalized from a specific sample to a defined population. In order to apply the results...
5.
Dickstein Y, Lellouche J, Schwartz D, Nutman A, Rakovitsky N, Dishon Benattar Y, et al.
Clin Infect Dis
. 2019 Nov;
71(10):2599-2607.
PMID: 31758195
Background: We evaluated whether carbapenem-colistin combination therapy reduces the emergence of colistin resistance, compared to colistin monotherapy, when given to patients with infections due to carbapenem-resistant Gram-negative organisms. Methods: This...
6.
Dickstein Y, Lellouche J, Ben Dalak Amar M, Schwartz D, Nutman A, Daitch V, et al.
Clin Infect Dis
. 2018 Nov;
69(5):769-776.
PMID: 30462182
Background: We evaluated the association between mortality and colistin resistance in Acinetobacter baumannii infections and the interaction with antibiotic therapy. Methods: This is a secondary analysis of a randomized controlled...
7.
Zak-Doron Y, Dishon Benattar Y, Pfeffer I, Daikos G, Skiada A, Antoniadou A, et al.
Clin Infect Dis
. 2018 May;
67(12):1815-1823.
PMID: 29718143
Background: Empirical colistin should be avoided. We aimed to evaluate the association between covering empirical antibiotics (EAT) and mortality for infections caused by carbapenem-resistant gram-negative bacteria (CRGNB). Methods: This was...
8.
Paul M, Daikos G, Durante-Mangoni E, Yahav D, Carmeli Y, Dishon Benattar Y, et al.
Lancet Infect Dis
. 2018 Feb;
18(4):391-400.
PMID: 29456043
Background: Colistin-carbapenem combinations are synergistic in vitro against carbapenem-resistant Gram-negative bacteria. We aimed to test whether combination therapy improves clinical outcomes for adults with infections caused by carbapenem-resistant or carbapenemase-producing...
9.
Paul M, Yahav D, Dishon Benattar Y, Leibovici L
Clin Infect Dis
. 2016 Dec;
64(5):696.
PMID: 27986667
No abstract available.
10.
Dishon Benattar Y, Omar M, Zusman O, Yahav D, Zak-Doron Y, Altunin S, et al.
Clin Infect Dis
. 2016 Oct;
63(12):1605-1612.
PMID: 27794023
Background: Optimizing colistin dosing should translate to improved patient outcomes. Methods: We used data from 2 prospective cohort studies performed between 2006 and 2009 and between 2012 and 2015. In...